Cheng Andrew bought AKRO
October 10, 2025 · Form 4 insider transaction
Cheng Andrew bought 30,000 shares of Akero Therapeutics, Inc. at $19.87 per share, a transaction worth $596.1K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
30,000
Price
$19.87
Total value
$596.1K
InsiderCheng Andrew
RoleOfficer, Director
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateOctober 10, 2025
Filing dateOctober 14, 2025
Shares owned after556,114
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The reported transactions were effected pursuant to a Rule 10b5-1 trading plan dated August 16, 2024, previously adopted by the Reporting Person.